Abstract
Critical illness is associated with multiple system organ dysfunction, and neurologic dysfunction is increasingly assessed and recognized. Neurologic dysfunction includes encephalopathy, cognitive, neuromuscular and psychiatric impairments, all of which can be severe and are associated with significant morbidity. Medical technological advances have improved central nervous system monitoring in critically ill patients, allowing quick and reliable diagnosis neurologic dysfunction such as delirium, sensory processing deficits, seizures, and encephalopathy to name a few. A number of neurologic evaluation tools are available to assess the neurologic status of critically ill patients both acutely, as well as longterm. Each tool provides unique information regarding neurologic status and has associated strengths and weakness. Identification of neurologic dysfunction allows for the development of working plans for prognostication, therapeutics, and rehabilitation that address the needs of each ICU survivor. This review focuses on the evaluation of neurologic sequelae during critical illness and long-term neurologic outcomes in survivors of critical illness.
Keywords: Cognitive sequelae, neurologic dysfunction, depression, quality of life, critical illness, ICU
Current Respiratory Medicine Reviews
Title: Neurologic Sequelae in Critical Illness: Evaluation and Outcomes
Volume: 3 Issue: 4
Author(s): Mary R. Suchyta and Ramona O. Hopkins
Affiliation:
Keywords: Cognitive sequelae, neurologic dysfunction, depression, quality of life, critical illness, ICU
Abstract: Critical illness is associated with multiple system organ dysfunction, and neurologic dysfunction is increasingly assessed and recognized. Neurologic dysfunction includes encephalopathy, cognitive, neuromuscular and psychiatric impairments, all of which can be severe and are associated with significant morbidity. Medical technological advances have improved central nervous system monitoring in critically ill patients, allowing quick and reliable diagnosis neurologic dysfunction such as delirium, sensory processing deficits, seizures, and encephalopathy to name a few. A number of neurologic evaluation tools are available to assess the neurologic status of critically ill patients both acutely, as well as longterm. Each tool provides unique information regarding neurologic status and has associated strengths and weakness. Identification of neurologic dysfunction allows for the development of working plans for prognostication, therapeutics, and rehabilitation that address the needs of each ICU survivor. This review focuses on the evaluation of neurologic sequelae during critical illness and long-term neurologic outcomes in survivors of critical illness.
Export Options
About this article
Cite this article as:
Suchyta R. Mary and Hopkins O. Ramona, Neurologic Sequelae in Critical Illness: Evaluation and Outcomes, Current Respiratory Medicine Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/157339807782359904
DOI https://dx.doi.org/10.2174/157339807782359904 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Type 2 Diabetes Mellitus and Invokana: An FDA Approved Drug
Current Diabetes Reviews The Effects of Sevoflurane or Remifentanil on the Stress Response to Surgical Stimulus
Current Pharmaceutical Design Glucose Transporters Regulation on Ischemic Brain: Possible Role as Therapeutic Target
Central Nervous System Agents in Medicinal Chemistry Metabolic Acidosis in Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Management of Hypertension in Relation to Acute Coronary Syndromes and Revascularisation
Current Pharmaceutical Design Serum Cystatin C-A Useful Endogenous Marker of Renal Function in Intensive Care Unit Patients at Risk for or with Acute Renal Failure?
Current Medicinal Chemistry Current Status of Computer-Aided Drug Design for Type 2 Diabetes
Current Computer-Aided Drug Design Reversible Michael Additions: Covalent Inhibitors and Prodrugs
Mini-Reviews in Medicinal Chemistry Is It Possible to Apply Secondary Stroke Prevention Guidelines to Very Old Populations?
Cardiovascular & Hematological Disorders-Drug Targets Artemisia Species as a New Candidate for Diabetes Therapy: A Comprehensive Review
Current Molecular Medicine Therapeutic Options for Transfusion Related Acute Lung Injury; the Potential of the G2A Receptor
Current Pharmaceutical Design Targeting CFTR: How to Treat Cystic Fibrosis by CFTR-Repairing Therapies
Current Drug Targets Therapeutic Hypothermia and Neuroprotection in Acute Neurological Disease
Current Medicinal Chemistry Hypersensitivity Reactions to Anticoagulant Drugs
Current Pharmaceutical Design Physiological Functions of NO-Sensitive Guanylyl Cyclase Isoforms
Current Medicinal Chemistry Is the Therapeutic Potential of Stem Cells for Myocardial Regeneration Limited by Proarrhythmic Effects?
Current Cardiology Reviews Drugs as Possible Triggers of Takotsubo Cardiomyopathy: A Comprehensive Literature Search - Update 2015
Current Clinical Pharmacology Iron Chelators in Medicinal Applications - Chemical Equilibrium Considerations in Pharmaceutical Activity
Current Medicinal Chemistry Selection Criteria for Probiotics and Potential of Cereal Based Food Products as Novel Probiotic-Carriers
Current Nutrition & Food Science Metal Toxicity and Speciation: A Review
Current Medicinal Chemistry